603363 傲农生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)14.01272.273-473.325-54.521--
总资产报酬率 ROA (%)4.4385.009-22.614-5.807--
投入资产回报率 ROIC (%)6.9488.532-36.180-8.807--

边际利润分析
销售毛利率 (%)7.4624.518-4.7394.3871.428
营业利润率 (%)6.3174.764-18.759-6.068-10.016
息税前利润/营业总收入 (%)8.0598.428-15.990-3.528-7.704
净利润/营业总收入 (%)6.9320.720-19.369-5.672-10.261

收益指标分析
经营活动净收益/利润总额(%)-13.991-1,746.76874.77866.58469.435
价值变动净收益/利润总额(%)107.2462,384.2340.1119.2483.292
营业外收支净额/利润总额(%)2.841-394.0220.855-1.2630.819

偿债能力分析
流动比率 (X)1.0220.8020.2460.439--
速动比率 (X)0.7640.6250.1290.157--
资产负债率 (%)58.62467.798103.69381.596--
带息债务/全部投入资本 (%)40.63048.79292.04463.425--
股东权益/带息债务 (%)133.01691.769-13.32732.036--
股东权益/负债合计 (%)62.31539.817-6.81616.453--
利息保障倍数 (X)5.1761.129-5.456-1.432-3.217

营运能力分析
应收账款周转天数 (天)23.43721.38510.7608.6770.000
存货周转天数 (天)39.25646.14840.77751.1960.000